Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update

Go back to Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
(NASDAQ: LFCR) Delayed: 4.42 +0.06 (1.38%)
Previous Close $4.36    52 Week High
Open $4.32    52 Week Low
Day High $4.45    P/E N/A 
Day Low $4.27    EPS
Volume 78,461